BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32162753)

  • 1. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: Effect on mortality and atrial fibrillation incidence.
    Singh JP; Cha YM; Lunati M; Chung ES; Li S; Smeets P; O'Donnell D
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):825-833. PubMed ID: 32009263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart Failure: The Randomized AMICA Trial.
    Kuck KH; Merkely B; Zahn R; Arentz T; Seidl K; Schlüter M; Tilz RR; Piorkowski C; Gellér L; Kleemann T; Hindricks G
    Circ Arrhythm Electrophysiol; 2019 Dec; 12(12):e007731. PubMed ID: 31760819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices.
    Steinberg BA; Li Z; O'Brien EC; Pritchard J; Chew DS; Bunch TJ; Mark DB; Nabutovsky Y; Greiner MA; Piccini JP
    Heart Rhythm; 2021 May; 18(5):709-716. PubMed ID: 33508517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Arai S; Kawamura M; Gokan T; Yoshikawa K; Ogawa K; Ochi A; Munetsugu Y; Ito H; Shinke T
    Clin Cardiol; 2020 Dec; 43(12):1517-1523. PubMed ID: 32989791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial.
    Botto GL; Boriani G; Favale S; Landolina M; Molon G; Tondo C; Biffi M; Grandinetti G; De Filippo P; Raciti G; Padeletti L
    Trials; 2011 Feb; 12():44. PubMed ID: 21324118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Detrimental Effect of RA Pacing on LA Function and Clinical Outcome in Cardiac Resynchronization Therapy.
    Martens P; Deferm S; Bertrand PB; Verbrugge FH; Ramaekers J; Verhaert D; Dupont M; Vandervoort PM; Mullens W
    JACC Cardiovasc Imaging; 2020 Apr; 13(4):895-906. PubMed ID: 31326478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.
    Leyva F; Zegard A; Qiu T; Acquaye E; Ferrante G; Walton J; Marshall H
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status - Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction.
    McManus DD; Hsu G; Sung SH; Saczynski JS; Smith DH; Magid DJ; Gurwitz JH; Goldberg RJ; Go AS;
    J Am Heart Assoc; 2013 Feb; 2(1):e005694. PubMed ID: 23525446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymptomatic episodes of device-registered atrial tachyarrhythmia are not associated with worse cardiac resynchronization therapy response.
    Verbrugge FH; Nijst P; Van Herendael H; De Vusser P; Jacobs L; Vercammen J; Verhaert D; Vandervoort P; Dupont M; Mullens W; Rivero-Ayerza M
    Europace; 2014 Aug; 16(8):1197-204. PubMed ID: 24489074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
    Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
    JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.
    Silva-Cardoso J; Zharinov OJ; Ponikowski P; Naditch-Brûlé L; Lewalter T; Brette S; Steg PG;
    Clin Cardiol; 2013 Dec; 36(12):766-74. PubMed ID: 24105492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy.
    Cai M; Hua W; Zhang N; Yang S; Hu Y; Gu M; Niu H; Zhang S
    BMC Cardiovasc Disord; 2020 May; 20(1):221. PubMed ID: 32404049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.